Korean Circ J.  2016 Jul;46(4):550-555. 10.4070/kcj.2016.46.4.550.

Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study

• Yoon YM
• Yun HW
• Kim SH

• KMID: 2344431
• DOI: http://doi.org/10.4070/kcj.2016.46.4.550

Abstract

BACKGROUND AND OBJECTIVES
Kawasaki disease (KD) is the leading cause of acquired heart disease, which predominantly occurs in children under the age of 5 years. However, there are fewer cases of KD in infants younger than 6 months, which makes it difficult to diagnose. We investigated the clinical manifestations of KD in this age group and compared them with those in the older age group.
SUBJECTS AND METHODS
We retrospectively reviewed the medical records of 239 patients with KD admitted to the Hallym Sacred Heart Hospital from January 2013 to June 2015. The data were categorized into 2 groups by age: Group A (≤6 months, n=26) and Group B (>6 months, n=213).
RESULTS
Group A had a longer hospitalization period than Group B (6.69 vs. 5.19 days, p=0.002). Group A had fewer clinical manifestations upon admission, due to which there was a higher incidence of incomplete KD (1.88 vs. 3.54 of the diagnostic criteria, p<0.05; and 19.2% vs. 4.2% incomplete KD incidence, p=0.002). The rate of cardiac complications was higher in Group A (30.8% vs. 11.7%, p=0.011).
CONCLUSION
The rate of cardiac complications of the patients younger than 6 months was significantly higher than that of the older patients. Therefore, infants younger than 6 months with unexplained fever for more than 5 days should be suspected as having KD, even if the principal clinical features are not fully presented. Echocardiography must be appropriately used for diagnosis of KD in suspected patients.

Keyword

Kawasaki disease; Complications; Coronary arteries; Infant

MeSH Terms

Child
Coronary Vessels
Diagnosis
Echocardiography
Fever
Heart
Heart Diseases
Hospitalization
Humans
Incidence
Infant*
Medical Records
Mucocutaneous Lymph Node Syndrome*
Retrospective Studies

Reference

1. Yeom JS, Woo HO, Park JS, Park ES, Seo JH, Youn HS. Kawasaki disease in infants. Korean J Pediatr. 2013; 56:377–382.

2. Hangai M, Kubota Y, Kagawa J, et al. Neonatal Kawasaki disease: case report and data from nationwide survey in Japan. Eur J Pediatr. 2014; 173:1533–1536.

3. Yu JJ. Diagnosis of incomplete Kawasaki disease. Korean J Pediatr. 2012; 55:83–87.

4. Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician. 2006; 74:1141–1148.

5. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110:2747–2771.

6. No SJ, Kim DO, Choi KM, Eun LY. Do predictors of incomplete Kawasaki disease exist for infants? Pediatr Cardiol. 2013; 34:286–290.

7. Park YW, Han JW, Park IS, et al. Epidemiologic study of Kawasaki disease in 6 months old and younger infants. Korean J Pediatr. 2008; 51:1320–1323.

8. Burns JC, Wiggins JW Jr, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr. 1986; 109:759–763.

9. Sánchez-Manubens J, Bou R, Anton J. Diagnosis and classification of Kawasaki disease. J Autoimmun. 2014; 48-49:113–117.

10. Bayers S, Shulman ST, Paller AS. Kawasaki disease: part II. Complications and treatment. J Am Acad Dermatol. 2013; 69:513.

11. Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E. Outcomes of Kawasaki disease: a single-center experience. Clin Pediatr (Phila). 2015; 54:579–584.

12. Verma P, Agarwal N, Maheshwari M. Recurrent Kawasaki disease. Indian Pediatr. 2015; 52:152–154.

13. Kim GB, Han JW, Park YW, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J. 2014; 33:24–27.

14. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med. 1995; 162:322–327.

15. Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY. Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect. 2006; 39:387–391.

16. Ram Krishna M, Sundaram B, Dhanalakshmi K. Predictors of coronary artery aneurysms in Kawasaki disease. Clin Pediatr (Phila). 2014; 53:561–565.

17. Bayers S, Shulman ST, Paller AS. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013; 69:501.e1–501.e11. quiz 511-2.

18. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J. 2006; 25:241–244.

19. Kim JJ, Hong YM, Yun SW, et al. Assessment of risk factors for Korean children with Kawasaki disease. Pediatr Cardiol. 2012; 33:513–520.

20. Jamieson N, Singh-Grewal D. Kawasaki disease: a clinician’s update. Int J Pediatr. 2013; 2013:645391.

21. Yeo Y, Kim T, Ha K, et al. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr. 2009; 168:157–162.

22. Lee EJ, Park YW, Hong YM, Lee JS, Han JW. Epidemiology of Kawasaki disease in infants 3 months of age and younger. Korean J Pediatr. 2012; 55:202–205.

23. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr. 1995; 126:524–529.